EssentialNews
USD USD 1.00 EUR EUR 0.88
USD USD 1.00 GBP GBP 0.75
USD USD 1.00 JPY JPY 163.68
USD USD 1.00 CAD CAD 1.41
USD USD 1.00 AUD AUD 1.43
USD USD 1.00 CHF CHF 0.82
USD USD 1.00 CNY CNY 6.78
USD USD 1.00 INR INR 96.62
USD USD 1.00 NGN NGN 1,366.59
USD USD 1.00 EUR EUR 0.88
USD USD 1.00 GBP GBP 0.75
USD USD 1.00 JPY JPY 163.68
USD USD 1.00 CAD CAD 1.41
USD USD 1.00 AUD AUD 1.43
USD USD 1.00 CHF CHF 0.82
USD USD 1.00 CNY CNY 6.78
USD USD 1.00 INR INR 96.62
USD USD 1.00 NGN NGN 1,366.59



ESSENTIAL NEWS
Breaking News • Analysis • Opinion
LATEST EDITION

BUSINESS

Analysts Forecast Mpc To Hold Interest Rate At 26.50%
Photo: Staff Photographer

ANALYSTS FORECAST MPC TO HOLD INTEREST RATE AT 26.50%

4 readers
shares
reactions
F

Financial analysts are predicting that the Monetary Policy Committee (MPC) of the Central Bank of Nigeria will maintain the benchmark interest rate at 26.50% during its upcoming meeting.

The expectation is based on the need to balance the fight against persistent inflation with the goal of supporting economic growth. Recent data showing moderating inflation figures and stable exchange rates have led many to believe that the current rate remains appropriate for the prevailing economic conditions.

Experts note that while inflationary pressures have eased somewhat, core inflation remains a concern, making a rate cut unlikely in the short term. They also highlighted the importance of maintaining policy consistency to anchor market expectations and preserve investor confidence.

The MPC’s decision will be closely watched by market participants, as it could influence lending rates, investment flows, and overall economic activity in the coming months. Analysts believe that a hold at the current level would provide a stable environment for businesses and households.

The Central Bank has been using monetary policy tools to address macroeconomic challenges, and the upcoming meeting is expected to provide further clarity on the direction of policy in the second half of the year.

READER ENGAGEMENT

SHARE THIS STORY